DE69413952D1 - Extraktion von zellgebundenem protein von bordetella - Google Patents

Extraktion von zellgebundenem protein von bordetella

Info

Publication number
DE69413952D1
DE69413952D1 DE69413952T DE69413952T DE69413952D1 DE 69413952 D1 DE69413952 D1 DE 69413952D1 DE 69413952 T DE69413952 T DE 69413952T DE 69413952 T DE69413952 T DE 69413952T DE 69413952 D1 DE69413952 D1 DE 69413952D1
Authority
DE
Germany
Prior art keywords
cell
pct
protein
bordetella
tied
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69413952T
Other languages
English (en)
Other versions
DE69413952T2 (de
Inventor
Carine Capiau
Martin Comberbach
Piet Roelants
Jean Petre
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
SmithKline Beecham Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA
Publication of DE69413952D1 publication Critical patent/DE69413952D1/de
Application granted granted Critical
Publication of DE69413952T2 publication Critical patent/DE69413952T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/02Separating microorganisms from their culture media
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K2039/10Brucella; Bordetella, e.g. Bordetella pertussis; Not used, see subgroups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82Proteins from microorganisms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82Proteins from microorganisms
    • Y10S530/825Bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Catalysts (AREA)
  • Saccharide Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
DE69413952T 1993-03-04 1994-02-28 Extraktion von zellgebundenem protein von bordetella Expired - Lifetime DE69413952T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939304399A GB9304399D0 (en) 1993-03-04 1993-03-04 Novel process
PCT/EP1994/000597 WO1994020538A1 (en) 1993-03-04 1994-02-28 Extraction of cell-bound protein from bordetella

Publications (2)

Publication Number Publication Date
DE69413952D1 true DE69413952D1 (de) 1998-11-19
DE69413952T2 DE69413952T2 (de) 1999-05-12

Family

ID=10731444

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69413952T Expired - Lifetime DE69413952T2 (de) 1993-03-04 1994-02-28 Extraktion von zellgebundenem protein von bordetella

Country Status (17)

Country Link
US (1) US6106842A (de)
EP (1) EP0687271B1 (de)
JP (1) JP3629555B2 (de)
KR (1) KR100290059B1 (de)
CN (1) CN1055702C (de)
AT (1) ATE172207T1 (de)
AU (1) AU673587B2 (de)
CA (1) CA2157375C (de)
DE (1) DE69413952T2 (de)
DK (1) DK0687271T3 (de)
ES (1) ES2125442T3 (de)
GB (1) GB9304399D0 (de)
HK (1) HK1012404A1 (de)
NZ (1) NZ262724A (de)
TW (1) TW390888B (de)
WO (1) WO1994020538A1 (de)
ZA (1) ZA941448B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6444211B2 (en) * 1991-04-03 2002-09-03 Connaught Laboratories, Inc. Purification of a pertussis outer membrane protein
GB9205704D0 (en) * 1992-03-16 1992-04-29 Connaught Lab High molecular weight membrane proteins of non-typeable haemophilus
US20040126853A1 (en) * 2002-06-20 2004-07-01 Novozymes A/S Flocculation with divalent salt
US8574589B2 (en) * 2009-05-11 2013-11-05 Novartis Ag Antigen purification process for pertactin antigen
KR102426041B1 (ko) * 2017-08-01 2022-07-29 주식회사 녹십자 냉동 및 해동 과정을 포함하는 백일해균 유래 단백질 수득 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3405218A (en) * 1965-09-22 1968-10-08 Parke Davis & Co Extracting bordetella pertussis antigens with lithium bromide
US3465078A (en) * 1965-10-21 1969-09-02 Sydney Z Spiesel Method of recovering antigens from bordetella pertussis cells
US3862109A (en) * 1968-10-12 1975-01-21 Hitachi Ltd Method for obtaining a protein isolate from hydrocarbon assimilating microbial cells
US4464474A (en) * 1980-07-09 1984-08-07 Connaught Laboratories Limited Non-A, non-B hepatitis assay and vaccine
GB8412207D0 (en) * 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
US5101014A (en) * 1989-02-10 1992-03-31 United States Of America Process for the purification of a 69,000 da outer membrane protein of Bordetella pertussis
US5276142A (en) * 1989-12-11 1994-01-04 American Cyanamid Company Process for purification of a 69000 dalton antigenic protein from Bordetella pertussis
US4988798A (en) * 1990-01-22 1991-01-29 Pitman-Moore, Inc. Method for recovering recombinant proteins
GB9007657D0 (en) * 1990-04-04 1990-05-30 Connaught Lab Purification of a pertussis outer membrane protein(omp69)

Also Published As

Publication number Publication date
DK0687271T3 (da) 1999-06-23
US6106842A (en) 2000-08-22
AU6257194A (en) 1994-09-26
KR100290059B1 (ko) 2001-05-15
CN1055702C (zh) 2000-08-23
JP3629555B2 (ja) 2005-03-16
AU673587B2 (en) 1996-11-14
ZA941448B (en) 1995-03-29
WO1994020538A1 (en) 1994-09-15
ATE172207T1 (de) 1998-10-15
CA2157375C (en) 2007-10-16
HK1012404A1 (en) 1999-07-30
ES2125442T3 (es) 1999-03-01
JPH08507763A (ja) 1996-08-20
TW390888B (en) 2000-05-21
DE69413952T2 (de) 1999-05-12
KR960701095A (ko) 1996-02-24
CN1121724A (zh) 1996-05-01
EP0687271B1 (de) 1998-10-14
EP0687271A1 (de) 1995-12-20
CA2157375A1 (en) 1994-09-15
NZ262724A (en) 1996-05-28
GB9304399D0 (en) 1993-04-21

Similar Documents

Publication Publication Date Title
ATE350131T1 (de) Verfahren zur behandlung von fluida
FI972093A0 (fi) Jäteveden käsittelymenetelmä ja -laitos
DE60015070D1 (de) Verwendung von antikonvulsiven derivaten zur behandlung der cluster headache
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
DK39693D0 (da) Enzym
ZA931318B (en) Method of treatment
MXPA03000612A (es) Metodos y procesos mejorados para desinfeccion con yodo.
EP0793660A4 (de) 2-substituierte 1,2,5-thiadiazolidin-3-on-1,1-dioxiden, zusammensetzung und deren verwendung
DE50108409D1 (de) Behandlung von oberflächen zur temporären verbesserung des schmutzablöseverhaltens
DE69413952D1 (de) Extraktion von zellgebundenem protein von bordetella
ATE185714T1 (de) Vorrichtung und verfahren zur reinigung von bestecken
HUT77868A (hu) Imidazopiridin-azolidinonok, ezeket tartalmazó gyógyszerkészítmények, alkalmazásuk és eljárás előállításukra
ES2060202T3 (es) Composicion detergente enzimatica liquida.
ATE251462T1 (de) Verfahren zur behandlung von narbengewebe
ATE548048T1 (de) Oncomodulin zur behandlung von neurologishen erkrankungen
HU9202354D0 (en) Method for reactivation of denatured protein
DK0809627T3 (da) Hidtil ukendte borneolderivater, fremgangsmåde til deres fremstilling og deres farmaceutiske anvendelse
DE69330246T2 (de) Impfstoffe auf der basis von streptokinase
NZ514691A (en) Method to type prion proteins
KR960702756A (ko) 방향성 물질을 확산시키는 방법 (metho for diffusing an odoriferous substance)
HU9601298D0 (en) Endothelin-converting enzyme
ATE328088T1 (de) Transketolase-verwandtes protein
ATE221068T1 (de) Anellierte beta-carboline
GR3027682T3 (en) 4-guanidinobutyramide for improving blood circulation.
UA36485A (uk) Спосіб лікування генералізованого пародонтиту

Legal Events

Date Code Title Description
8364 No opposition during term of opposition